Procoagulant Platelets and the Pathways Leading to Cell Death

 

 Buy Article Permissions and Reprints

Abstract

Platelets are critical mediators of thrombosis and hemostasis. In response to agonist, platelets aggregate to form a thrombus via ligand binding of the glycoprotein IIb/IIIa receptor. However, activated platelets are heterogeneous in nature and a subset of platelets stimulated by strong agonists support the assembly of the coagulation complexes. It is proposed that these “procoagulant” platelets have a unique role in hemostasis and thrombosis as the link between primary and secondary hemostasis, localizing the thrombin burst required for fibrin formation to micro-domains within the platelet thrombus. Loss of procoagulant potential leads to bleeding while an increase is linked with propensity to thrombosis. While many features of the procoagulant platelet are known, the exact nature of the procoagulant platelet remains controversial. It is noted that many of the morphological and biochemical features of procoagulant platelets are also features of the cyclophilin D necrosis pathway. This review will focus on the distinct roles of platelet subpopulations, the identity of the procoagulant platelet, and the potential role of the cell death pathways in regulating platelet procoagulant response.

• References

• 1 Jackson SP. The growing complexity of platelet aggregation. Blood 2007; 109 (12) 5087-5095
  CrossrefPubMedGoogle Scholar
• 2 Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 2011; 9 (Suppl. 01) 92-104
  PubMedGoogle Scholar
• 3 Monroe DM, Hoffman M. What does it take to make the perfect clot?. Arterioscler Thromb Vasc Biol 2006; 26 (1) 41-48
  CrossrefPubMedGoogle Scholar
• 4 Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 2000; 95 (5) 1694-1702
  CrossrefPubMedGoogle Scholar
• 5 Kempton CL, Hoffman M, Roberts HR, Monroe DM. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol 2005; 25 (4) 861-866
  CrossrefPubMedGoogle Scholar
• 6 Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002; 100 (3) 743-754
  CrossrefPubMedGoogle Scholar
• 7 Hoffman M, Monroe III DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85 (6) 958-965
  PubMedGoogle Scholar
• 8 Yang H, Kim A, David T , et al. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 2012; 151 (1) 111-122
  CrossrefPubMedGoogle Scholar
• 9 Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468 (7325) 834-838
  CrossrefPubMedGoogle Scholar
• 10 Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996; 87 (4) 1409-1415
  PubMedGoogle Scholar
• 11 van Kruchten R, Mattheij NJA, Saunders C , et al. Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation. Blood 2013; 121 (10) 1850-1857
  CrossrefPubMedGoogle Scholar
• 12 Jackson SP. Arterial thrombosis—insidious, unpredictable and deadly. Nat Med 2011; 17 (11) 1423-1436
  CrossrefPubMedGoogle Scholar
• 13 Kirkpatrick AC, Stoner JA, Dale GL, Prodan CI. Elevated coated-platelets in symptomatic large-artery stenosis patients are associated with early stroke recurrence. Platelets 2014; 25 (2) 93-96
  CrossrefPubMedGoogle Scholar
• 14 Collaboration AT. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324 (7329) 71-86
  CrossrefPubMedGoogle Scholar
• 15 Dale GL, Friese P, Batar P , et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415 (6868) 175-179
  CrossrefPubMedGoogle Scholar
• 16 Yakimenko AO, Verholomova FY, Kotova YN, Ataullakhanov FI, Panteleev MA. Identification of different proaggregatory abilities of activated platelet subpopulations. Biophys J 2012; 102 (10) 2261-2269
  CrossrefPubMedGoogle Scholar
• 17 Topalov NN, Yakimenko AO, Canault M , et al. Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3). Arterioscler Thromb Vasc Biol 2012; 32 (10) 2475-2483
  CrossrefPubMedGoogle Scholar
• 18 Bevers EM, Comfurius P, van Rijn JLML, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122 (2) 429-436
  CrossrefPubMedGoogle Scholar
• 19 Jobe SM, Wilson KM, Leo L , et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 2008; 111 (3) 1257-1265
  PubMedGoogle Scholar
• 20 Fager AM, Wood JP, Bouchard BA, Feng P, Tracy PB. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arterioscler Thromb Vasc Biol 2010; 30 (12) 2400-2407
  CrossrefPubMedGoogle Scholar
• 21 Munnix ICA, Kuijpers MJE, Auger J , et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol 2007; 27 (11) 2484-2490
  CrossrefPubMedGoogle Scholar
• 22 Heemskerk JW, Vuist WM, Feijge MA, Reutelingsperger CP, Lindhout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood 1997; 90 (7) 2615-2625
  CrossrefPubMedGoogle Scholar
• 23 Kulkarni S, Jackson SP. Platelet factor XIII and calpain negatively regulate integrin alphaIIbbeta3 adhesive function and thrombus growth. J Biol Chem 2004; 279 (29) 30697-30706
  CrossrefPubMedGoogle Scholar
• 24 Mattheij NJA, Gilio K, van Kruchten R , et al. Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets. J Biol Chem 2013; 288 (19) 13325-13336
  CrossrefPubMedGoogle Scholar
• 25 Nesbitt WS, Westein E, Tovar-Lopez FJ , et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009; 15 (6) 665-673
  CrossrefPubMedGoogle Scholar
• 26 Munnix IC, Cosemans JM, Auger JM, Heemskerk JW. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009; 102 (6) 1149-1156
  PubMedGoogle Scholar
• 27 von Brühl ML, Stark K, Steinhart A , et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209 (4) 819-835
  CrossrefPubMedGoogle Scholar
• 28 Voronov RS, Stalker TJ, Brass LF, Diamond SL. Simulation of intrathrombus fluid and solute transport using in vivo clot structures with single platelet resolution. Ann Biomed Eng 2013; 41 (6) 1297-1307
  CrossrefPubMedGoogle Scholar
• 29 Furihata K, Clemetson KJ, Deguchi H, Kunicki TJ. Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase activity. Arterioscler Thromb Vasc Biol 2001; 21 (11) 1857-1863
  CrossrefPubMedGoogle Scholar
• 30 Pasquet JM, Toti F, Nurden AT, Dachary-Prigent J. Procoagulant activity and active calpain in platelet-derived microparticles. Thromb Res 1996; 82 (6) 509-522
  CrossrefPubMedGoogle Scholar
• 31 Smeets EF, Heemskerk JW, Comfurius P, Bevers EM, Zwaal RF. Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb Haemost 1993; 70 (6) 1024-1029
  PubMedGoogle Scholar
• 32 Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991; 266 (36) 24302-24307
  PubMedGoogle Scholar
• 33 London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem 2004; 279 (19) 19854-19859
  CrossrefPubMedGoogle Scholar
• 34 Butenas S, van't Veer C, Mann KG. “Normal” thrombin generation. Blood 1999; 94 (7) 2169-2178
  PubMedGoogle Scholar
• 35 Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol 2005; 25 (2) 467-471
  PubMedGoogle Scholar
• 36 Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J. Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 2009; 89 (4) 374-384
  CrossrefPubMedGoogle Scholar
• 37 Batar P, Dale GL. Simultaneous engagement of thrombin and Fc γ RIIA receptors results in platelets expressing high levels of procoagulant proteins. J Lab Clin Med 2001; 138 (6) 393-402
  CrossrefPubMedGoogle Scholar
• 38 Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88 (2) 186-193
  PubMedGoogle Scholar
• 39 Feng P, Tracy PB. Not all platelets are equivalent procoagulants. Blood 1998; 92: 1441a
  PubMedGoogle Scholar
• 40 Kuijpers MJE, Schulte V, Oury C , et al. Facilitating roles of murine platelet glycoprotein Ib and alphaIIbbeta3 in phosphatidylserine exposure during vWF-collagen-induced thrombus formation. J Physiol 2004; 558 (Pt 2) 403-415
  CrossrefPubMedGoogle Scholar
• 41 Prodan CI, Stoner JA, Cowan LD, Dale GL. Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction. J Cereb Blood Flow Metab 2013; 33 (2) 287-292
  CrossrefPubMedGoogle Scholar
• 42 Brown SB, Clarke MC, Magowan L, Sanderson H, Savill J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J Biol Chem 2000; 275 (8) 5987-5996
  CrossrefPubMedGoogle Scholar
• 43 Kile BT. The role of apoptosis in megakaryocytes and platelets. Br J Haematol 2014; 165 (2) 217-226
  CrossrefPubMedGoogle Scholar
• 44 White MJ, Schoenwaelder SM, Josefsson EC , et al. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function. Blood 2012; 119 (18) 4283-4290
  CrossrefPubMedGoogle Scholar
• 45 Mason KD, Carpinelli MR, Fletcher JI , et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128 (6) 1173-1186
  CrossrefPubMedGoogle Scholar
• 46 Schoenwaelder SM, Jackson SP. Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function. Blood 2012; 119 (5) 1320-1321 , author reply 1321–1322
  CrossrefPubMedGoogle Scholar
• 47 Josefsson EC, White MJ, Dowling MR, Kile BT. Platelet life span and apoptosis. Methods Mol Biol 2012; 788: 59-71
  PubMedGoogle Scholar
• 48 Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006; 4 (12) 2656-2663
  CrossrefPubMedGoogle Scholar
• 49 Li S, Wang Z, Liao Y , et al. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost 2010; 8 (2) 341-350
  CrossrefPubMedGoogle Scholar
• 50 Arachiche A, Kerbiriou-Nabias D, Garcin I, Letellier T, Dachary-Prigent J. Rapid procoagulant phosphatidylserine exposure relies on high cytosolic calcium rather than on mitochondrial depolarization. Arterioscler Thromb Vasc Biol 2009; 29 (11) 1883-1889
  CrossrefPubMedGoogle Scholar
• 51 Schoenwaelder SM, Yuan Y, Josefsson EC , et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114 (3) 663-666
  CrossrefPubMedGoogle Scholar
• 52 Schoenwaelder SM, Jarman KE, Gardiner EE , et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood 2011; 118 (6) 1663-1674
  CrossrefPubMedGoogle Scholar
• 53 Festjens N, Vanden Berghe T, Vandenabeele P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 2006; 1757 (9-10) 1371-1387
  CrossrefPubMedGoogle Scholar
• 54 Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev 2006; 20 (1) 1-15
  CrossrefPubMedGoogle Scholar
• 55 Nakagawa T, Shimizu S, Watanabe T , et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434 (7033) 652-658
  CrossrefPubMedGoogle Scholar
• 56 Choo H-J, Saafir TB, Mkumba L, Wagner MB, Jobe SM. Mitochondrial calcium and reactive oxygen species regulate agonist-initiated platelet phosphatidylserine exposure. Arterioscler Thromb Vasc Biol 2012; 32 (12) 2946-2955
  CrossrefPubMedGoogle Scholar
• 57 Reményi G, Szász R, Debreceni IB , et al. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment. Platelets 2013; 24 (6) 486-492
  CrossrefPubMedGoogle Scholar
• 58 Prodan CI, Vincent AS, Dale GL. Coated-platelet levels are elevated in patients with transient ischemic attack. Transl Res 2011; 158 (1) 71-75
  CrossrefPubMedGoogle Scholar